Paratek Pharmaceuticals, Inc. (PRTK): Price and Financial Metrics


Paratek Pharmaceuticals, Inc. (PRTK)

Today's Latest Price: $5.15 USD

0.04 (0.78%)

Updated Jul 2 4:00pm

Add PRTK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

PRTK Stock Summary

  • Paratek Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 7.09% of US listed stocks.
  • With a price/sales ratio of 9.85, Paratek Pharmaceuticals Inc has a higher such ratio than 87.4% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -6.8 for Paratek Pharmaceuticals Inc; that's greater than it is for merely 2.53% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Paratek Pharmaceuticals Inc are GEVO, AQST, KALA, JAGX, and AVGR.
  • PRTK's SEC filings can be seen here. And to visit Paratek Pharmaceuticals Inc's official web site, go to paratekpharma.com.
PRTK Daily Price Range
PRTK 52-Week Price Range

PRTK Stock Price Chart Technical Analysis Charts


PRTK Price/Volume Stats

Current price $5.15 52-week high $5.89
Prev. close $5.11 52-week low $2.50
Day low $5.01 Volume 483,749
Day high $5.35 Avg. volume 758,055
50-day MA $4.57 Dividend yield N/A
200-day MA $3.91 Market Cap 222.13M

Paratek Pharmaceuticals, Inc. (PRTK) Company Bio


Paratek Pharmaceuticals focuses on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry in the United States. The company was founded in 1996 and is based in in Boston, Massachusetts.


PRTK Latest News Stream


Event/TimeNews Detail
Loading, please wait...

PRTK Latest Social Stream


Loading social stream, please wait...

View Full PRTK Social Stream

Latest PRTK News From Around the Web

Below are the latest news stories about Paratek Pharmaceuticals Inc that investors may wish to consider to help them evaluate PRTK as an investment opportunity.

Should You Avoid Paratek Pharmaceuticals Inc (PRTK)?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

Yahoo | July 5, 2020

Paratek Pharma files for $250M mixed shelf

Paratek Pharmaceuticals (PRTK) has filed a preliminary prospectus for a $250M mixed shelf offering....

Seeking Alpha | June 19, 2020

Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders

Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today announced its virtual 2020 Annual Meeting of Stockholders (the “Annual Meeting”) will now be held at 9:00 a.m. Eastern Time. As described in the proxy materials previously distributed for the Annual Meeting, stockholders as of the close of business on April 13, 2020, the record date, may attend the meeting virtually via the Internet at www.virtualshareholdermeeting.com/PRTK2020 by entering the 16-digit control number found in such proxy materials or, for stockholders that hold their shares in “street name,” by followi...

Yahoo | May 29, 2020

Paratek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare Conference

Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today announced that the Company will present at the Jefferies 2020 Virtual Healthcare Conference, Wednesday, June 3, 2020 at 8:00 a.m. ET. To access the live webcast of Paratek's presentation, please visit http://wsw.com/webcast/jeff126/prtk/. Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use.

Yahoo | May 28, 2020

Paratek Pharmaceuticals to Present at Bank of America Securities 2020 Health Care Conference

Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today announced that the Company will present at Bank of America Securities 2020 Health Care Conference, Wednesday, May 13, 2020 at 11:40 a.m. ET. To access the live webcast of Paratek's presentation, please visit http://www.veracast.com/webcasts/bofa/healthcare2020/id57206441686.cfm. Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, governmen...

Yahoo | May 11, 2020

Read More 'PRTK' Stories Here

PRTK Price Returns

1-mo 4.89%
3-mo 28.43%
6-mo 23.50%
1-year 30.71%
3-year -78.41%
5-year -79.55%
YTD 27.79%
2019 -21.44%
2018 -71.34%
2017 16.23%
2016 -18.82%
2015 -50.79%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9777 seconds.